Bilateral atypical femoral fractures after long-term alendronate therapy: a case report
Bamrungsong, T.; Pongchaiyakul, C.
Journal of the Medical Association of Thailand 93(5): 620-624
2010
ISSN/ISBN: 0125-2208 PMID: 20524451 Document Number: 11169
Bisphosphonates therapy has been shown to decrease the risk of vertebral, non-vertebral, and hip fractures in postmenopausal women. However the long-term safety of bisphosphonates use has been questioned. Recent reports have demonstrated the association between long-term alendronate therapy with low-energy subtrochanteric fracture or diaphyseal femoral fractures in a small number of patients. The author reported the first case of bilateral atypical femoral fractures in postmenopausal women with osteoporosis receiving long-term alendronate therapy.
Document emailed within 1 workday
